Clinical Trials Logo

Clinical Trial Summary

The main aim of the study is the evaluation of the feasibility of comprehensive service which has been developed while considering patient-orientated needs. With regard to the study, apps have been developed for both groups of participants, parents and their child which suffers from cancer. These apps aim at supporting the documentation and communication of the own condition. This includes for example a video game which can be played via tablet or smartphone in which questions appear addressing the personally perceived burden by children amongst other things. Participants of the study are children between 6 and 17 years of age which suffer from leukemia or tumors. Further participants of the study are at least one of the patient's parents. It is an observational study. Within the course of the study, the usual treatment is not altered actively by the study, it is, however, supplemented by questionnaires which will be analyzed being anonymized after the end of the study running time.


Clinical Trial Description

The study is designed as observational prospective feasibility study. The main objective is to assess the feasibility of a comprehensive, patient-centred service for palliative care in children with cancer by adapting and advancing ePRO systems, which aim at supporting the communication between the patients, their parents and the treating medical healthcare professionals. Participants of the study are pediatric oncology patients between 6 and 17 years of age and at least one of their parents, receiving treatment at one of the participating clinical centers due to leukemia or solid tumors. With regard to the study, apps have been developed for both groups of participants, which includes inter alia a game in which questions about burden considering symptoms can be answered by the children. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04381221
Study type Observational
Source Centre for Research and Technology Hellas
Contact Norbert Graf, Professor MD
Phone +49 68411628411
Email graf@uks.eu
Status Recruiting
Phase
Start date December 22, 2020
Completion date September 2022

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03936465 - Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer Phase 1
Recruiting NCT04899505 - Evaluation of the Impact of Chemotherapy on Body Odor in Adolescents and Young Adults in Oncology
Recruiting NCT03465592 - Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma Phase 1/Phase 2
Recruiting NCT03373656 - Vaccination for Children of H&O and Their Parents N/A
Recruiting NCT05481502 - An Exploratory Study to Evaluate Immune Determinants of the Response to Adoptive Cell Therapy (ACT) in Solid and Hematologic Tumors N/A
Recruiting NCT05042479 - Using of Virtual Reality to Relieve Procedural Pain in Pediatric Oncology. N/A
Recruiting NCT04471961 - Analyse of Tumour and Constitutional DNA for the Study of the Determinism in Child Neoplasia N/A
Recruiting NCT04485416 - Pilot Trial of Eltrombopag in Patients Undergoing Chemotherapy for Malignant Solid Tumors Phase 1
Recruiting NCT03086421 - Social Emotional Development in Young Children With Cancer
Terminated NCT04671901 - A Study of Romiplostim to Prevent Low Platelet Counts in Children and Young Adults Receiving Chemotherapy for Solid Tumors Phase 2
Not yet recruiting NCT05633719 - Multicenter, Prospective Observational Study for Early Diagnosis, and Development of Follow-up Protocol and Hearing Rehabilitation Program for Ototoxic Hearing Loss After Chemotherapy for Pediatric Solid Cancer